<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): NOVEMBER 26, 1997
-----------------
APPLIED SCIENCE AND TECHNOLOGY, INC.
(Exact name of registrant as specified in its charter)
DELAWARE 0-22646 04-2962110
-------- ------- ----------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification No.)
incorporation)
35 CABOT ROAD, WOBURN, MASSACHUSETTS 01801
---------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (781) 933-5560
--------------
<PAGE> 2
ITEM 5. OTHER EVENTS.
On November 26, 1997, the Registrant publicly disseminated a press release
announcing that at its Annual Meeting of Stockholders held on November 20, 1997,
the stockholders of the Registrant approved an increase in the authorized shares
of the Registrant to 30 million and a 3-for-2 stock split of its Common Stock to
be effected in the form of a stock dividend. Each stockholder of record at the
close of business on November 28, 1997 will receive a stock dividend at the rate
of one share of Common Stock for every two shares of Common Stock owned. The
Registrant will distribute the new stock certificates to stockholders on or
about December 12, 1997. Stockholders will not be entitled to receive any
resulting fractional shares, but will receive the value of any such fractional
shares in cash based on the fair market value of such shares on November 28,
1997. Appropriate adjustments will be made in the number of shares of Common
Stock reserved for issuance and/or issuable under (i) the Company's 1987 Stock
Option Plan, 1993 Stock Option Plan, as amended, and 1994 Formula Stock Option
Plan, and upon exercise of all outstanding options under such Plans, and (ii)
any outstanding warrants. The information contained in the press release is
incorporated herein by reference and filed as Exhibit 99.1 hereto.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(c) Exhibit.
Exhibit
No. Title
------- -----
99.1 The Registrant's Press Release, dated November 26, 1997.
2
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
APPLIED SCIENCE AND TECHNOLOGY, INC.
Date: December 8, 1997 /s/ John M. Tarrh
----------------------------------------
John M. Tarrh
Senior Vice President and Chief
Financial Officer
3
<PAGE> 4
EXHIBIT INDEX
-------------
Exhibit Sequential
Number Description Page Number
- ------ ----------- -----------
99.1 The Registrant's Press Release 5
dated November 26, 1997
4
<PAGE> 1
Contact: John Tarrh
Applied Science and Technology, Inc.
Senior Vice President and Chief Financial Officer
(781) 937-5135
Investor Relations Contact:
Donna N. Stein, APR/Dan Durkin/Keil Decker
Morgen-Walke Associates, Inc.
(212) 850-5600
FOR IMMEDIATE RELEASE Press Contact: Lee Foley
Morgen-Walke Associates, Inc.
(212) 850-5600
ASTEX SHAREHOLDERS APPROVE 3-FOR-2 STOCK SPLIT
Woburn, Mass., November 26, 1997 ---- Applied Science and Technology, Inc.
("ASTeX") (NASDAQ: ASTX) today announced the shareholder approval of an increase
in its authorized shares to 30 million and a 3-for-2 stock split of its Common
Stock to be effected in the form of a stock dividend. Each shareholder of record
at the close of business on November 28, 1997 will receive a stock dividend at
the rate of one share of Common Stock for every two shares of Common Stock
owned. The Company will distribute the new stock certificates to shareholders on
or about December 12, 1997. Shareholders will not be entitled to receive any
resulting fractional shares, but will receive the value of any such fractional
shares in cash.
ASTeX is a leading provider of innovative production technology for the
manufacture of advanced semiconductor devices. ASTeX markets its plasma sources
and subsystems, ozone generators and subsystems, and specialty powersources to
the world's leading semiconductor capital equipment manufacturers. ASTeX markets
the same underlying core technology for medical, electro-optic and synthetic
diamond applications.
